STOCKSCREENR
Log In

CTEV

NYSE

Claritev Corporation

$16.92-0.68(-3.86%)Mkt Cap: $280.07M

Key Stats

Market Cap

$280.07M

P/E Ratio

-0.98

EPS

$-17.30

Dividend Yield

0.00%

52-Week Range

$12.04 — $74.07

Volume

130.66K

Avg Volume

242.01K

Beta

0.68

Valuation

P/E (TTM)

-0.98

Forward P/E

—

PEG Ratio

-0.06

P/S (TTM)

0.30

P/B (TTM)

-1.63

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

3.78%

ROA (TTM)

-0.06%

ROIC

—

Gross Margin

0.28%

Operating Margin

0.05%

Net Margin

—

Debt/Equity

-26.64

Current Ratio

0.86

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-7.56%

EPS Growth (5Y)

-29.78%

Sales Growth (3Y)

-0.06%

Sales Growth (5Y)

-0.01%

EPS Est (This Year)

$-8.98

EPS Est (Next Year)

$-6.79

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$1.02

Analyst Consensus

Price Target Range

$30.00$34.00$38.00
LowMedianHigh

Consensus Target: $34.00(100.9% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

16.53M

Float

7.05M

Free Float %

42.68%

About

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Country

US

Exchange

NYSE

IPO Date

2020-04-03

Employees

2700

CEO

Travis S. Dalton

Index Membership

—

Website

https://www.claritev.com

Claritev Corporation (CTEV) is a healthcare company in the medical - healthcare information services industry listed on the NYSE. With a market capitalization of $280.07M, a P/E ratio of -0.98, CTEV is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare CTEV against other stocks using dozens of fundamental and technical filters.

Similar Stocks

SOPH

SOPHiA GENETICS S.A.

$5.00

+1.83%

$358.34M

SDGR

Schrödinger, Inc.

$12.29

-3.23%

$907.31M

CARL

CARLSMED, INC.

$11.70

+0.00%

$312.76M

HCAT

Health Catalyst, Inc.

$1.17

-3.70%

$86.10M

SLP

Simulations Plus, Inc.

$11.92

-1.65%

$240.15M

KSI.TO

Kneat.com, Inc.

$3.72

+0.27%

$356.33M

Frequently Asked Questions

What is Claritev Corporation's P/E ratio?

Claritev Corporation (CTEV) has a trailing twelve-month (TTM) P/E ratio of -0.98. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Claritev Corporation pay a dividend?

No, Claritev Corporation (CTEV) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Claritev Corporation's market cap?

Claritev Corporation (CTEV) has a market capitalization of $280.07 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.